SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-172532
Filing Date
2023-06-22
Accepted
2023-06-22 16:06:00
Documents
12
Period of Report
2023-06-21
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d517350d8k.htm   iXBRL 8-K 31211
  Complete submission text file 0001193125-23-172532.txt   149261

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA dcph-20230621.xsd EX-101.SCH 2857
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE dcph-20230621_lab.xml EX-101.LAB 17236
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dcph-20230621_pre.xml EX-101.PRE 10817
6 EXTRACTED XBRL INSTANCE DOCUMENT d517350d8k_htm.xml XML 3221
Mailing Address 200 SMITH STREET WALTHAM MA 02451
Business Address 200 SMITH STREET WALTHAM MA 02451 781-209-6400
Deciphera Pharmaceuticals, Inc. (Filer) CIK: 0001654151 (see all company filings)

IRS No.: 200299725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38219 | Film No.: 231033377
SIC: 2834 Pharmaceutical Preparations